Cargando…
Unleashing The Potential Of Multiple-Targeted Therapies In Hepatobiliary Cancers: Two Cases, Cocktail Therapy With Nine Molecular Targeted Agents And Long-Lasting Survival
The mortality of hepatobiliary cancer still stays high around the world, with disappointing treatment status at advanced stage. Genomic analysis has identified the global spectrum of alterations in liver cancer, but the most common mutations are not actionable, meanwhile lacking potent molecular-tar...
Autores principales: | Lin, Jianzhen, Yang, Xiaobo, Xie, Yuan, Zhao, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875264/ https://www.ncbi.nlm.nih.gov/pubmed/31819490 http://dx.doi.org/10.2147/OTT.S223568 |
Ejemplares similares
-
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
por: Patel, Sheylan D., et al.
Publicado: (2020) -
Combination treatment including targeted therapy for advanced hepatocellular carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2016) -
Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers
por: Yang, Xu, et al.
Publicado: (2021) -
Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs
por: Velychko, Sergiy, et al.
Publicado: (2019) -
Robotics in hepatobiliary surgery-initial experience, first reported case series from India
por: Goja, S., et al.
Publicado: (2017)